血液炎症生物标志物在肺癌诊断及预测 TNM 分期中的作用。
The Role of Hematological Inflammatory Biomarkers in the Diagnosis of Lung Cancer and in Predicting TNM Stage.
机构信息
Department of Nuclear Medicine, Recep Tayyip Erdogan University Training and Research Hospital, Rize, Turkey.
Department of Chest Disease, Recep Tayyip Erdogan University Training and Research Hospital, Rize, Turkey.
出版信息
Cancer Invest. 2021 Jul-Aug;39(6-7):514-520. doi: 10.1080/07357907.2021.1938110. Epub 2021 Jun 23.
OBJECTIVE
The aim of study is to investigate whether hematological inflammatory biomarkers could be useful to detect patients with lung cancer.
METHODS
The contribution of hematological biomarkers to the diagnosis of lung cancer and prediction of TNM was examined.
RESULTS
NLR, PLR, MPV values were found to be higher in patients with lung cancer (all < .001). NLR and PLR were found to be high, MPV was found to be lower in disease of advanced stage ( < .001).
CONCLUSIONS
This study found that NLR, PLR and MPV values were significantly higher in patients with lung cancer.
目的
研究旨在探讨血液学炎症生物标志物是否可用于检测肺癌患者。
方法
研究检查了血液生物标志物对肺癌诊断和 TNM 预测的贡献。
结果
发现肺癌患者的 NLR、PLR、MPV 值较高（均 <.001）。发现晚期疾病患者的 NLR 和 PLR 较高，MPV 较低（<.001）。
结论
本研究发现肺癌患者的 NLR、PLR 和 MPV 值显著升高。
Zotero 插件